Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Longbow Finance SA

Key Points

• Longbow Finance SA increased its stake in Intuitive Surgical by 132.0% during Q1, acquiring an additional 11,209 shares, bringing its total holdings to $9,756,000.
• Several institutional investors, including Norges Bank and GAMMA Investing LLC, have significantly increased their positions in Intuitive Surgical amidst growing interest, with institutional ownership now at 83.64%.
• Analysts have mixed views on Intuitive Surgical, with Royal Bank of Canada raising the target price to $615.00 while Deutsche Bank downgraded it to $440.00, leading to a consensus rating of "Moderate Buy".

Longbow Finance SA increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 132.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,699 shares of the medical equipment provider's stock after purchasing an additional 11,209 shares during the period. Intuitive Surgical accounts for about 1.2% of Longbow Finance SA's holdings, making the stock its 23rd biggest holding. Longbow Finance SA's holdings in Intuitive Surgical were worth $9,756,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Castleark Management LLC raised its stake in shares of Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after acquiring an additional 2,990 shares during the period. Arlington Trust Co LLC increased its holdings in Intuitive Surgical by 34.5% in the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after purchasing an additional 191 shares during the last quarter. Aaron Wealth Advisors LLC raised its position in Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after purchasing an additional 78 shares during the period. Ewing Morris & Co. Investment Partners Ltd. acquired a new position in Intuitive Surgical during the fourth quarter worth $454,000. Finally, Whalerock Point Partners LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $209,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 1.5%

Shares of NASDAQ ISRG traded up $7.25 during mid-day trading on Friday, reaching $495.86. The company had a trading volume of 1,870,941 shares, compared to its average volume of 1,842,693. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a market cap of $177.76 billion, a P/E ratio of 69.16, a PEG ratio of 5.53 and a beta of 1.64. The firm has a 50 day simple moving average of $529.86 and a two-hundred day simple moving average of $535.07.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business's quarterly revenue was up 21.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.78 EPS. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director owned 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the transaction, the executive vice president owned 5,224 shares in the company, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,798 shares of company stock valued at $3,955,331 over the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Barclays dropped their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. BTIG Research lifted their target price on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday. Robert W. Baird dropped their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Piper Sandler restated an "overweight" rating and issued a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday. Finally, Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $592.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.